“anti-TNF drugs”的搜索结果，显示 511-520 项，共有 6886 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Ascorbic acid may make cancer cells more sensitive to chemotherapy. Drugs used in chemotherapy, work in different ways to stop the growth of cancer cells, ...

2. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... therapy and compare it to the biopsy performed prior to cancer treatment. Tumor ... Chemotherapy drugs, such as methotrexate, vinblastine, doxorubicin ...

4. 神经科- 临床试验- 妙佑医疗国际

   To describe the clinical features along with treatment outcomes of a cohort of patients with a diagnosis of NMOSD after the latest revised criteria in 2015 by ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Iberdomide, Daratumumab, Bortezomib, And Dexamethasone For Treatment Of Newly Diagnosed Multiple Myeloma, IDEAL Study. Rochester, Minn. The purpose of this ...

6. 血液科- 临床试验- 妙佑医疗国际

   The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

7. 血液科- 临床试验- 妙佑医疗国际

   Drugs used in chemotherapy work in different ways to stop the growth of ... treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step ...

8. 神经科- 临床试验- 妙佑医疗国际

   ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...

9. 神经科- 临床试验- 妙佑医疗国际

   Patients in cohorts 1.11 and 1.12 (currently lacking detectable cancer) will undergo the collection at least 4 weeks after conclusion of therapy. In addition to ...

10. 神经科- 临床试验- 妙佑医疗国际

    ... Therapy. Rochester, Minn. The purpose of this study is to estimate the efficacy of LUTATHERA treatment in patients with recurrent grade 1 meningioma as ...